AI Enabled IND & NDA - Special Inaugural Workshop

Written By Guest User

Join the AAIH at 0830hr EST for a FULL DAY workshop (Hotel Eaton, Washington D.C.)

READ MORE ON OUR PUBLICATIONS PAGE TO DOWNLOAD THE PDF

The first amongst a series, our programming will explore how AI will impact end-to-end drug development including patient presentation and diagnosis, understanding disease biology, disease biology modulation, clinical studies, and real-world evidence. Participants will discuss and explore: 

  1. How AI is currently being used to develop or repurpose new drugs

  2. How our understanding of biology will impact AI enabled patient-driven R&D paradigms for yesterday, today and tomorrow

  3. Key challenges and implications around AI-derived data including economics, ethics/bias, technology and infrastructure requirements

Guest User
Previous

JPM 2020: The Impact of AI: How AI and ML are Transforming R&D and What's Next to Come
Next

Alliance for Artificial Intelligence in Healthcare Releases Primer to Advance Understanding within the Industry